Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Symbol Digit Modalities Test-Oral Version: An Analysis of Culture Influence on a Processing Speed Test in Argentina, Mexico, and the USA.

Eizaguirre MB, Vanotti SI, Aguayo Arelis A, Rabago Barajas B, Cores EV, Macías MA, Benedict RHB, Cáceres F.

Dev Neuropsychol. 2020 Mar 12:1-10. doi: 10.1080/87565641.2020.1737699. [Epub ahead of print]

PMID:
32164460
2.

Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.

Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

Neurobiol Aging. 2020 Feb 8. pii: S0197-4580(20)30029-4. doi: 10.1016/j.neurobiolaging.2020.02.002. [Epub ahead of print]

PMID:
32147244
3.

Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis.

B D'hooghe M, De Cock A, Van Remoortel A, Benedict RHB, Eelen P, Peeters E, D'haeseleer M, De Keyser J, Nagels G.

Mult Scler Relat Disord. 2019 Dec 20;39:101904. doi: 10.1016/j.msard.2019.101904. [Epub ahead of print]

PMID:
31981931
4.

Recovery of cognitive function after relapse in multiple sclerosis.

Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B.

Mult Scler. 2020 Jan 23:1352458519898108. doi: 10.1177/1352458519898108. [Epub ahead of print]

PMID:
31971066
5.

A Technique Utilizing GraftNet to Fill Graft Donor Sites in Bone-Patellar-Bone Anterior Cruciate Ligament Reconstruction.

Mead RN, Benedict R, Limpisvasti O.

Arthrosc Tech. 2019 Nov 13;8(12):e1469-e1472. doi: 10.1016/j.eats.2019.07.029. eCollection 2019 Dec.

6.

A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.

Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

J Neurol. 2020 Mar;267(3):802-811. doi: 10.1007/s00415-019-09643-z. Epub 2019 Nov 25.

PMID:
31768628
7.

Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Wojcik CM, Beier M, Costello K, DeLuca J, Feinstein A, Goverover Y, Gudesblatt M, Jaworski M 3rd, Kalb R, Kostich L, LaRocca NG, Rodgers JD, Benedict RH; National MS Society Cognition Work Team.

Mult Scler. 2019 Dec;25(14):1848-1869. doi: 10.1177/1352458519879094. Epub 2019 Oct 22.

8.

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.

Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH.

Mult Scler. 2019 Oct 15:1352458519881428. doi: 10.1177/1352458519881428. [Epub ahead of print]

PMID:
31610732
9.

Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis.

Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG.

Hum Brain Mapp. 2019 Dec 15;40(18):5231-5241. doi: 10.1002/hbm.24768. Epub 2019 Aug 24.

PMID:
31444887
10.

Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.

Jakimovski D, Kuhle J, Ramanathan M, Barro C, Tomic D, Hagemeier J, Kropshofer H, Bergsland N, Leppert D, Dwyer MG, Michalak Z, Benedict RHB, Weinstock-Guttman B, Zivadinov R.

Ann Clin Transl Neurol. 2019 Sep;6(9):1757-1770. doi: 10.1002/acn3.50872. Epub 2019 Aug 22. Erratum in: Ann Clin Transl Neurol. 2019 Dec;6(12):2607.

11.

Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.

Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-Guttman B, Zivadinov R, Benedict RHB.

Mult Scler Relat Disord. 2019 Sep;34:103-111. doi: 10.1016/j.msard.2019.06.026. Epub 2019 Jun 22.

PMID:
31254960
12.

Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis.

Fuchs TA, Benedict RH, Wilding G, Wojcik C, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG.

Mult Scler. 2019 Jun 20:1352458519858605. doi: 10.1177/1352458519858605. [Epub ahead of print]

PMID:
31219390
13.

Perceived neuropsychological impairment inversely related to self-reported health and employment in multiple sclerosis.

D'hooghe MB, De Cock A, Benedict RHB, Gielen J, Van Remoortel A, Eelen P, Van Merhaegen A, De Keyser J, D'Haeseleer M, Peeters E, Nagels G.

Eur J Neurol. 2019 Dec;26(12):1447-1454. doi: 10.1111/ene.14012. Epub 2019 Jul 8.

PMID:
31183915
14.

Cognitive Profiles of Aging in Multiple Sclerosis.

Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M 3rd, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R, Benedict RHB.

Front Aging Neurosci. 2019 May 10;11:105. doi: 10.3389/fnagi.2019.00105. eCollection 2019.

15.

Epidemiology and treatment of multiple sclerosis in elderly populations.

Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B.

Nat Rev Neurol. 2019 Jun;15(6):329-342. doi: 10.1038/s41582-019-0183-3. Review.

PMID:
31000816
16.

Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.

Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B, Zivadinov R.

Mult Scler. 2020 Feb;26(2):201-209. doi: 10.1177/1352458518819608. Epub 2019 Jan 9.

PMID:
30625030
17.

Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.

Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH.

Mult Scler. 2020 Feb;26(2):245-252. doi: 10.1177/1352458518820272. Epub 2019 Jan 7.

PMID:
30615562
18.

Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.

Chapman BP, Lin F, Roy S, Benedict RHB, Lyness JM.

Personal Disord. 2019 Jan;10(1):46-58. doi: 10.1037/per0000300.

19.

Distal purse-string suture technique for TaTME.

Wu R, Benedict R, Caycedo-Marulanda A.

Tech Coloproctol. 2019 Jan;23(1):67-68. doi: 10.1007/s10151-018-1917-8. Epub 2018 Dec 22. No abstract available.

20.

Dalfampridine benefits ambulation but not cognition in multiple sclerosis.

Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-Guttman B, Motl R, Benedict RH.

Mult Scler. 2020 Jan;26(1):91-98. doi: 10.1177/1352458518815795. Epub 2018 Dec 19.

PMID:
30566030
21.

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium.

Vaughn CB, Kavak KS, Dwyer MG, Bushra A, Nadeem M, Cookfair DL, Ramanathan M, Benedict RH, Zivadinov R, Goodman A, Krupp L, Motl RW, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium.

Mult Scler. 2020 Jan;26(1):99-108. doi: 10.1177/1352458518816619. Epub 2018 Dec 3.

PMID:
30507270
22.

Effectiveness of programmes and interventions to support optimal breastfeeding among children 0-23 months, South Asia: A scoping review.

Benedict RK, Craig HC, Torlesse H, Stoltzfus RJ.

Matern Child Nutr. 2018 Nov;14 Suppl 4:e12697. doi: 10.1111/mcn.12697. Review.

23.

Trends and predictors of optimal breastfeeding among children 0-23 months, South Asia: Analysis of national survey data.

Benedict RK, Craig HC, Torlesse H, Stoltzfus RJ.

Matern Child Nutr. 2018 Nov;14 Suppl 4:e12698. doi: 10.1111/mcn.12698.

24.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2020 Jan;26(1):109-113. doi: 10.1177/1352458518813287. Epub 2018 Nov 22.

PMID:
30465463
25.

Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures.

Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Choudhery S, Carolus K, Rooney P, Ashton K, P Ramasamy D, Jakimovski D, Zivadinov R, Dwyer MG.

Mult Scler Relat Disord. 2019 Jan;27:298-304. doi: 10.1016/j.msard.2018.11.005. Epub 2018 Nov 9.

PMID:
30453198
26.

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.

Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N, Hudson LD, Rudick RA, LaRocca NG; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2019 Nov;25(13):1781-1790. doi: 10.1177/1352458518808204. Epub 2018 Oct 18.

27.

Recommendations for cognitive screening and management in multiple sclerosis care.

Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J.

Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10. Review.

28.

Integrative CNS Plasticity With Exercise in MS: The PRIMERS (PRocessing, Integration of Multisensory Exercise-Related Stimuli) Conceptual Framework.

Sandroff BM, Motl RW, Reed WR, Barbey AK, Benedict RHB, DeLuca J.

Neurorehabil Neural Repair. 2018 Oct;32(10):847-862. doi: 10.1177/1545968318798938. Epub 2018 Sep 12.

PMID:
30205784
29.

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.

Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R.

J Neurol Sci. 2018 Oct 15;393:128-134. doi: 10.1016/j.jns.2018.08.020. Epub 2018 Aug 23.

PMID:
30165291
30.

Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.

Lichter DG, Benedict RHB, Hershey LA.

J Parkinsons Dis. 2018;8(4):539-552. doi: 10.3233/JPD-181375.

PMID:
30124451
31.

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.

Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B, Zivadinov R.

Eur J Neurol. 2019 Jan;26(1):87-e8. doi: 10.1111/ene.13769. Epub 2018 Sep 3.

PMID:
30103277
32.

Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.

Feenaughty L, Tjaden K, Weinstock-Guttman B, Benedict RHB.

Am J Speech Lang Pathol. 2018 Aug 6;27(3):1051-1065. doi: 10.1044/2018_AJSLP-17-0174.

33.

A decline in cognitive function should lead to a change in disease-modifying therapy - Yes.

Weinstock-Guttman B, Eckert S, Benedict RH.

Mult Scler. 2018 Nov;24(13):1681-1682. doi: 10.1177/1352458518783364. Epub 2018 Jul 16. Review. No abstract available.

PMID:
30010476
34.

Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition.

Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T, Dwyer MG.

Mult Scler. 2019 Aug;25(9):1243-1254. doi: 10.1177/1352458518788218. Epub 2018 Jul 13.

PMID:
30004291
35.

Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.

Fuchs TA, Carolus K, Benedict RHB, Bergsland N, Ramasamy D, Jakimovski D, Weinstock-Guttman B, Kuceyeski A, Zivadinov R, Dwyer MG.

AJNR Am J Neuroradiol. 2018 Aug;39(8):1480-1486. doi: 10.3174/ajnr.A5720. Epub 2018 Jul 5.

36.

Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.

Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

Hum Brain Mapp. 2018 Oct;39(10):4007-4017. doi: 10.1002/hbm.24227. Epub 2018 Jun 19.

37.

Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.

Woodward MR, Hafeez MU, Qi Q, Riaz A, Benedict RHB, Yan L, Szigeti K; Texas Alzheimer's Research, Care Consortium.

Am J Geriatr Psychiatry. 2018 Aug;26(8):835-846. doi: 10.1016/j.jagp.2018.02.008. Epub 2018 Apr 19.

38.

White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.

Fuchs TA, Dwyer MG, Kuceyeski A, Choudhery S, Carolus K, Li X, Mallory M, Weinstock-Guttman B, Jakimovski D, Ramasamy D, Zivadinov R, Benedict RHB.

Hum Brain Mapp. 2018 Sep;39(9):3682-3690. doi: 10.1002/hbm.24203. Epub 2018 May 8.

PMID:
29740964
39.

Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.

Roy S, Drake A, Snyder S, Cline B, Khan A, Fuchs T, Zivadinov R, Weinstock-Guttman B, Szigeti K, Benedict RHB.

Mult Scler Relat Disord. 2018 May;22:52-56. doi: 10.1016/j.msard.2018.03.008. Epub 2018 Mar 13.

PMID:
29574353
40.

Longitudinal personality change associated with cognitive decline in multiple sclerosis.

Roy S, Drake A, Fuchs T, Dwyer MG, Zivadinov R, Chapman BP, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2018 Jan 1:1352458517753720. doi: 10.1177/1352458517753720. [Epub ahead of print]

PMID:
29363385
41.

Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosis.

Covey TJ, Shucard JL, Benedict RH, Weinstock-Guttman B, Shucard DW.

Mult Scler J Exp Transl Clin. 2018 Jan 11;4(1):2055217317747626. doi: 10.1177/2055217317747626. eCollection 2018 Jan-Mar.

42.

Cognition in multiple sclerosis: State of the field and priorities for the future.

Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S.

Neurology. 2018 Feb 6;90(6):278-288. doi: 10.1212/WNL.0000000000004977. Epub 2018 Jan 17. Review.

43.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
44.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct;24(11):1469-1484. doi: 10.1177/1352458517723718. Epub 2017 Aug 11. Review.

45.

Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J, Sahraian MA, Marques VD, Langdon D.

Clin Neuropsychol. 2018 Jan;32(1):54-62. doi: 10.1080/13854046.2017.1354071. Epub 2017 Jul 19.

PMID:
28721748
46.

Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.

Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K.

Psychiatry Res Neuroimaging. 2017 Aug 30;266:90-95. doi: 10.1016/j.pscychresns.2017.06.004. Epub 2017 Jun 9.

47.

Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.

Chapman BP, Benedict RHB, Lin F, Roy S, Porteinsson A, Szigeti K, Federoff H, Mapstone M.

Int J Geriatr Psychiatry. 2018 Feb;33(2):332-339. doi: 10.1002/gps.4748. Epub 2017 Jun 14.

PMID:
28612377
48.

Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients.

van der Hiele K, van Gorp D, Benedict R, Jongen PJ, Arnoldus E, Beenakker E, Bos HM, van Eijk J, Fermont J, Frequin S, van Geel BM, Hengstman G, Hoitsma E, Hupperts R, Mostert JP, Pop P, Verhagen W, Zemel D, Frndak SE, Heerings M, Middelkoop H, Visser LH.

Mult Scler J Exp Transl Clin. 2016 Nov 24;2:2055217316680638. doi: 10.1177/2055217316680638. eCollection 2016 Jan-Dec.

49.

BICAMS in the Argentine population: Relationship with clinical and sociodemographic variables.

Vanotti S, Smerbeck A, Eizaguirre MB, Saladino ML, Benedict RRH, Caceres FJ.

Appl Neuropsychol Adult. 2018 Sep-Oct;25(5):424-433. doi: 10.1080/23279095.2017.1323751. Epub 2017 May 23.

PMID:
28534643
50.

Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study.

Benedict RH, Cohan S, Lynch SG, Riester K, Wang P, Castro-Borrero W, Elkins J, Sabatella G.

Mult Scler. 2018 May;24(6):795-804. doi: 10.1177/1352458517707345. Epub 2017 May 9.

Supplemental Content

Loading ...
Support Center